Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Apr;52(4):568-73.
doi: 10.1136/gut.52.4.568.

Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases

N C Tebbutt  1 , A R Norman, D Cunningham, M E Hill, D Tait, J Oates, S Livingston, J Andreyev
Affiliations

Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases

N C Tebbutt et al. Gut. 2003 Apr.

Abstract

Background: The role of palliative resection of the primary tumour in patients who present with metastatic colorectal cancer is unclear.

Aims: This study compared the incidence of major intestinal complications in such patients who received chemotherapy treatment with or without prior palliative resection of the primary tumour.

Patients: The incidence of intestinal obstruction, perforation, fistula formation, and gastrointestinal haemorrhage, and the requirement for abdominal radiotherapy in patients with metastatic colorectal cancer treated at a single institution over a 10 year period was determined.

Results: Eighty two patients received initial treatment with chemotherapy without resection of the primary tumour (unresected group) and 280 patients had undergone prior resection (resected group). In the unresected group, the incidence of peritonitis, fistula formation, and intestinal haemorrhage was 2.4% (95% confidence interval (CI) 0.3-8.5%), 3.7% (95% CI 0.8-10.3%), and 3.7% (95% CI 0.8-10.3%), respectively, and was not significantly different from the resected group. Intestinal obstruction affected 13.4% (95% CI 6.9-22.7%) of patients in the unresected group and 13.2% (95% CI 9.2-17.2%) of patients in the resected group. More patients in the unresected group required >/=3 blood transfusions (14.6% v 7.5%; p=0.048) and abdominal radiotherapy (18.3% v 9.6%; p=0.03) than the resected group.

Conclusions: The incidence of major intestinal complications in patients with unresected colorectal cancer and synchronous metastases who receive initial treatment with chemotherapy is low. Chemotherapy may be successfully used as initial treatment for such patients with no increased risk of most major intestinal complications compared with patients who have undergone initial resection of the primary tumour.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Comparison of time until the development of intestinal obstruction in the unresected and resected groups (p=0.11). (B) Comparison of time until the development of intestinal obstruction in patients with (PeriOmental) and without (No PeriOm) peritoneal or omental metastases (p=0.006).
See this image and copyright information in PMC

References

    1. McArdle CS, Hole D, Hansell D, et al. Prospective study of colorectal cancer in the west of Scotland: 10-year follow-up. Br J Surg 1990;77:280–2. - PubMed
    1. Mella J, Biffin A, Radcliffe AG, et al. Population-based audit of colorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit. Br J Surg 1997;84:1731–6. - PubMed
    1. Ellis H. Curative and palliative surgery in advanced carcinoma of the large bowel. BMJ 1971; 3:291–3. - PMC - PubMed
    1. Makela J, Haukipuro K, Laitinen S, et al. Palliative operations for colorectal cancer. Dis Colon Rectum 1990;33:846–50. - PubMed
    1. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457–81.

MeSH terms